Kids’ Cancer Research Foundation Featured in Tribune Article as Year End Donation Idea

Share Article

Director of Kids’ Cancer Research Foundation (KCF), Frank Kalman, was recently interviewed for an article in San Luis Obispo’s Tribune newspaper.

neuroblastoma, kids cancer research foundation, year end donation

Frank Kalman, Founder of Kids' Cancer Research Foundation, with his daughter, a survivor of a childhood cancer

I honestly can’t think of a better organization than the Kids’ Cancer Research Foundation.

The San Luis Obispo’s Tribune newspaper recently featured the local charitable organization Kids’ Cancer Research Foundation, which aims to provide financial support for research and clinical trials that will cure Neuroblastoma (NB), with an emphasis on non-toxic treatments. The article suggests KCRF as an ideal year-end tax deductible donation idea as they mainly help infants and toddlers battling a very specific type of pediatric oncology.

“We truly appreciate the acknowledgement in our local paper,” says Frank Kalman, Director of the non-profit Kids’ Cancer Research Foundation (KCRF). “As people evaluate where they should donate at the end of the year, this article could not have come at a better time.”

The San Luis Obispo Tribune article was posted around the time of the holidays and friends and loved ones gather for annual family celebrations. It notes that there has been an increase in the number of people being diagnosed with cancer.

The Tribune article states: “If you’d like to help lessen the odds, and need a tax shelter before the end of the year, I honestly can’t think of a better organization than the Kids’ Cancer Research Foundation.”

The article also shared insight from Frank who offered advice to those seeking help: "Get at least three opinions; research the type of cancer diagnosed for your loved one; and go to a hospital that specializes in and focuses on that type of cancer."

Kids’ Cancer Research, which was founded and is run by Frank, the father of a young woman who was diagnosed with Neuroblastoma, thinks that even losing one child a year from this form of cancer is one too many. Currently, KCRF is working with researchers on a mouse anti-body and T-cell therapy “combos” or “CAR T-Cell therapy.”

Supporters of KCRF, whether through just an email subscription or through a financial donation, are being kept up to date on the progress these researchers are seeing by Frank himself. The progress they have seen in the last year on a T-Cell trial they have endorsed has been recognized for its promise by doctors in the industry.

Anyone is welcome to sign up for these updates or support the 501c3 foundation at http://www.endkidscancer.org.

About Kids Cancer Research Foundation
The mission of the Kids’ Cancer Research Foundation is to provide financial support for research and clinical trials that will cure Neuroblastoma (NB), with an emphasis on non-toxic treatments. Our narrow focus on Neuroblastoma is designed to increase the success of finding a cure. Less than half the infants and toddlers survive to adulthood. While the focus is narrow, the benefits derived will be broad. At the time of this writing, approximately 32 other cancers will benefit from advancements made in Neuroblastoma research. Some of the more commonly known are: breast cancer, kidney cancer, brain cancer, liver cancer, and melanoma. Donations are highly encouraged at http://www.endkidscancer.org/donate.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

FRANK KALMAN
KIDS' CANCER RESEARCH FOUNDATION
805-550-7682
Email >
Visit website